Edgewise 治疗公司
US ˙ NasdaqGS ˙ US28036F1057

介绍

本页面提供了有关 John R Moore 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示John R Moore已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:EWTX / Edgewise Therapeutics, Inc. General Counsel 10,214
US:04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020 VP, General Counsel 40,102
US:NVLS / Nivalis Therapeutics, Inc. Director 12,300
如何解读这些图表

以下图表显示了在John R Moore进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

EWTX / Edgewise Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分,我们分析了在 EWTX / Edgewise Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

EWTX / Edgewise Therapeutics, Inc. Insider Trades
EWTX / Edgewise Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 EWTX / Edgewise Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
2025-08-12 EWTX MOORE JOHN R 2,098 13.3924 2,098 13.3924 28,097 0 13.3900 -5 -0.02
2025-05-02 EWTX MOORE JOHN R 1,930 16.4542 1,930 16.4542 31,757
2024-09-23 EWTX MOORE JOHN R 20,922 27.6295 20,922 27.6295 578,064
2024-09-20 EWTX MOORE JOHN R 50,000 28.3702 50,000 28.3702 1,418,510
2024-05-02 EWTX MOORE JOHN R 1,956 18.9100 1,956 18.9100 36,988
2024-02-09 EWTX MOORE JOHN R 8,029 20.0096 8,029 20.0096 160,657
2024-02-08 EWTX MOORE JOHN R 3,813 20.0065 3,813 20.0065 76,285
2024-02-07 EWTX MOORE JOHN R 17,993 20.0002 17,993 20.0002 359,864
2023-05-02 EWTX MOORE JOHN R 1,897 8.9049 1,897 8.9049 16,893
2022-08-03 EWTX MOORE JOHN R 9,232 9.3069 9,232 9.3069 85,921
2022-07-06 EWTX MOORE JOHN R 1,046 8.5352 1,046 8.5352 8,928
2022-07-05 EWTX MOORE JOHN R 8,186 8.3470 8,186 8.3470 68,329
2022-06-21 EWTX MOORE JOHN R 31,078 7.2944 31,078 7.2944 226,695
2022-06-17 EWTX MOORE JOHN R 22,127 6.6179 22,127 6.6179 146,434
2022-06-16 EWTX MOORE JOHN R 14,722 6.1680 14,722 6.1680 90,805
2022-06-15 EWTX MOORE JOHN R 585 6.1104 585 6.1104 3,575
2022-06-15 EWTX MOORE JOHN R 18,075 6.1104 18,075 6.1104 110,445
2022-06-14 EWTX MOORE JOHN R 3,628 6.0239 3,628 6.0239 21,855
2022-06-13 EWTX MOORE JOHN R 4,093 6.0058 4,093 6.0058 24,582
2022-06-10 EWTX MOORE JOHN R 7,125 6.0519 7,125 6.0519 43,120
2022-06-09 EWTX MOORE JOHN R 7,615 6.4868 7,615 6.4868 49,397
2022-06-08 EWTX MOORE JOHN R 12,566 6.6339 12,566 6.6339 83,362
2022-06-07 EWTX MOORE JOHN R 973 6.6050 973 6.6050 6,427
2022-06-07 EWTX MOORE JOHN R 17,150 6.6050 17,150 6.6050 113,276
2022-06-06 EWTX MOORE JOHN R 13,934 6.0345 13,934 6.0345 84,085
2022-06-03 EWTX MOORE JOHN R 15,230 6.0537 15,230 6.0537 92,198

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

EWTX / Edgewise Therapeutics, Inc. Insider Trades
内幕交易历史

该表格显示了由 John R Moore 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2025-08-14 2025-08-12 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -2,098 10,214 -17.04 13.39 -28,097 136,790
2025-08-14 2025-08-12 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,781 12,312 88.52
2025-05-07 2025-05-02 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -1,930 6,531 -22.81 16.45 -31,757 107,462
2025-05-07 2025-05-01 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,209 8,461 160.18
2024-09-24 2024-09-23 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -20,922 3,252 -86.55 27.63 -578,064 89,851
2024-09-24 2024-09-23 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 20,922 24,174 643.36 0.71 14,855 17,164
2024-09-24 2024-09-20 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -50,000 3,252 -93.89 28.37 -1,418,510 92,260
2024-09-24 2024-09-20 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 50,000 53,252 1,537.52 0.71 35,500 37,809
2024-05-03 2024-05-02 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -1,956 3,252 -37.56 18.91 -36,988 61,495
2024-05-03 2024-05-01 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,208 5,208
2024-02-09 2024-02-09 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -8,029 0 -100.00 20.01 -160,657
2024-02-09 2024-02-09 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 8,029 8,029 1.93 15,496 15,496
2024-02-09 2024-02-08 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -3,813 0 -100.00 20.01 -76,285
2024-02-09 2024-02-08 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 3,813 3,813 1.93 7,359 7,359
2024-02-09 2024-02-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -17,993 0 -100.00 20.00 -359,864
2024-02-09 2024-02-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 17,993 17,993 1.93 34,726 34,726
2023-12-28 2023-12-27 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -8,497 0 -100.00 10.50 -89,218
2023-05-03 2023-05-02 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -1,897 6,565 -22.42 8.90 -16,893 58,461
2023-05-03 2023-05-01 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,208 8,462 160.05
2022-10-05 2022-10-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -4,730 3,000 -61.19 9.76 -46,155 29,274
2022-10-05 2022-10-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 4,730 7,730 157.67 1.93 9,129 14,919
2022-09-08 2022-09-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -2,351 3,000 -43.94 10.99 -25,842 32,976
2022-09-08 2022-09-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -2,379 5,351 -30.78 10.83 -25,756 57,931
2022-09-08 2022-09-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 4,730 7,730 157.67 1.93 9,129 14,919
2022-08-05 2022-08-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -9,232 3,000 -75.47 9.31 -85,921 27,921
2022-08-05 2022-08-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 4,502 12,232 58.24 0.71 3,196 8,685
2022-08-05 2022-08-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 4,730 7,730 157.67 1.93 9,129 14,919
2022-07-07 2022-07-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -1,046 3,000 -25.85 8.54 -8,928 25,606
2022-07-07 2022-07-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 1,046 4,046 34.87 1.93 2,019 7,809
2022-07-07 2022-07-05 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -8,186 3,000 -73.18 8.35 -68,329 25,041
2022-07-07 2022-07-05 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 4,502 11,186 67.35 0.71 3,196 7,942
2022-07-07 2022-07-05 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 3,684 6,684 122.80 1.93 7,110 12,900
2022-06-21 2022-06-21 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -31,078 3,000 -91.20 7.29 -226,695 21,883
2022-06-21 2022-06-21 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 17,570 34,078 106.43 1.93 33,910 65,771
2022-06-21 2022-06-21 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 13,508 16,508 450.27 0.71 9,591 11,721
2022-06-21 2022-06-17 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -22,127 3,000 -88.06 6.62 -146,434 19,854
2022-06-21 2022-06-17 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 22,127 25,127 737.57 1.93 42,705 48,495
2022-06-21 2022-06-16 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -14,722 3,000 -83.07 6.17 -90,805 18,504
2022-06-21 2022-06-16 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 14,722 17,722 490.73 1.93 28,413 34,203
2022-06-15 2022-06-15 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -18,075 3,000 -85.77 6.11 -110,445 18,331
2022-06-15 2022-06-15 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -585 21,075 -2.70 6.11 -3,575 128,777
2022-06-15 2022-06-15 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 585 21,660 2.78 1.93 1,129 41,804
2022-06-15 2022-06-15 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 18,075 21,075 602.50 0.71 12,833 14,963
2022-06-15 2022-06-14 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -3,628 3,000 -54.74 6.02 -21,855 18,072
2022-06-15 2022-06-14 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 3,628 6,628 120.93 0.71 2,576 4,706
2022-06-15 2022-06-13 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -4,093 3,000 -57.70 6.01 -24,582 18,017
2022-06-15 2022-06-13 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 4,093 7,093 136.43 0.71 2,906 5,036
2022-06-10 2022-06-10 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -7,125 3,000 -70.37 6.05 -43,120 18,156
2022-06-10 2022-06-10 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 7,125 10,125 237.50 0.71 5,059 7,189
2022-06-10 2022-06-09 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -7,615 3,000 -71.74 6.49 -49,397 19,460
2022-06-10 2022-06-09 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 7,615 10,615 253.83 0.71 5,407 7,537
2022-06-10 2022-06-08 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -12,566 3,000 -80.73 6.63 -83,362 19,902
2022-06-10 2022-06-08 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 12,566 15,566 418.87 0.71 8,922 11,052
2022-06-07 2022-06-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -17,150 3,000 -85.11 6.60 -113,276 19,815
2022-06-07 2022-06-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 17,150 20,150 571.67 0.71 12,176 14,306
2022-06-07 2022-06-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -973 3,000 -24.49 6.60 -6,427 19,815
2022-06-07 2022-06-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 973 3,973 32.43 1.93 1,878 7,668
2022-06-07 2022-06-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -13,934 3,000 -82.28 6.03 -84,085 18,104
2022-06-07 2022-06-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 13,934 16,934 464.47 1.93 26,893 32,683
2022-06-07 2022-06-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -15,230 3,000 -83.54 6.05 -92,198 18,161
2022-06-07 2022-06-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 15,230 18,230 507.67 1.93 29,394 35,184
2022-05-18 2022-05-16 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -10,800 3,000 -78.26 7.42 -80,146 22,263
2022-05-03 2022-05-01 4 EWTX Edgewise Therapeutics, Inc.
Restricted Stock Units
A - Award 15,625 15,625
2022-01-25 2022-01-21 4 EWTX Edgewise Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -5,400 205,322 -2.56
2022-01-25 2022-01-21 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,400 12,362 77.56 0.71 3,834 8,777
2021-12-30 2021-12-28 4 EWTX Edgewise Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -5,400 210,722 -2.50
2021-12-30 2021-12-28 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,400 6,962 345.71 0.71 3,834 4,943
2021-08-19 2021-08-17 4 EWTX Edgewise Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 120,000 120,000
2017-04-06 2017-04-01 4/A ARRY ARRAY BIOPHARMA INC
Common Stock
F - Taxes -6,370 40,102 -13.71 8.94 -56,948 358,512
2017-04-04 2017-04-01 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
M - Exercise -6,718 20,157 -25.00
2017-04-04 2017-04-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
F - Taxes -4,408 42,064 -9.49 8.94 -39,408 376,052
2017-04-04 2017-04-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 6,718 46,472 16.90
2016-12-29 2016-12-27 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 131,250 131,250
2016-12-29 2016-12-27 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 21,875 21,875
2016-09-14 2016-09-12 4 NVLS Nivalis Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12,300 12,300
2016-04-05 2016-04-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 161,250 161,250
2016-04-05 2016-04-01 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 26,875 26,875
2016-04-05 2016-04-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
F - Taxes -2,505 39,754 -5.93 3.00 -7,515 119,262
2015-09-15 2015-09-11 4 NVLS Nivalis Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 7,650 7,650
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
4,326
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
4,326
2015-04-03 2015-04-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 161,250 161,250
2015-04-03 2015-04-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
A - Award 26,875 42,259 174.69
2015-03-04 2015-03-01 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
M - Exercise -22,906 22,906 -50.00
2015-03-04 2015-03-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
F - Taxes -7,542 15,364 -32.93 7.96 -60,034 122,297
2015-03-04 2015-03-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 22,906 22,906 7.96 182,332 182,332
2014-08-20 2014-08-18 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 45,812 45,812
2014-04-03 2014-04-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 125,000 125,000
2013-12-03 2013-11-29 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -11,666 20 -99.83 5.79 -67,546 116
2013-11-15 2013-11-13 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -200 11,686 -1.68 5.79 -1,158 67,662
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise X -30,000 30,000 -50.00
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise X -13,884 9,375 -59.69
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -43,884 11,886 -78.69 7.03 -308,469 83,549
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 30,000 55,770 116.41 3.06 91,800 170,656
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 13,884 25,770 116.81 3.01 41,791 77,568
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise X -14,241 23,259 -37.98
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise X -12,500 12,500 -50.00
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -31,500 11,886 -72.60 7.00 -220,635 83,253
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 14,241 43,386 48.86 3.01 42,865 130,592
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 12,500 29,145 75.10 2.74 34,250 79,857
2013-07-25 2013-07-25 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -4,759 0 -100.00
2013-07-25 2013-07-25 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 4,759 16,645 40.04 3.75 17,846 62,419
2013-07-25 2013-07-23 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -5,000 25,000 -16.67
2013-07-25 2013-07-23 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -5,000 11,886 -29.61 6.50 -32,500 77,259
2013-07-25 2013-07-23 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 5,000 16,886 42.07 2.74 13,700 46,268
2013-04-24 2013-04-23 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -20,000 30,000 -40.00
2013-04-24 2013-04-23 4 ARRY ARRAY BIOPHARMA INC
Common Stock
D - Sale to Issuer X -20,000 11,886 -62.72 6.52 -130,400 77,497
2013-04-24 2013-04-23 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 20,000 31,886 168.27 2.74 54,800 87,368
2013-04-01 2013-03-28 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 80,000 80,000
2012-10-09 2012-10-08 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -2,357 0 -100.00 5.69 -13,401
2012-10-09 2012-10-08 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -26,190 11,886 -68.78 5.69 -148,911 67,581
2012-10-05 2012-10-04 4 ARRY ARRAY BIOPHARMA INC
Common Stock
A - Award 11,886 38,076 45.38
2012-04-03 2012-03-30 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 75,000 75,000
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)